US$ 20.21
glp 1 drugs available in usa One four US adults with diabetes used a GLP-1 drug last year, survey finds GLP-1 drugs, which have grown
Description
References Jastreboff, A
An intensive multifactorial cardiovascular risk intervention targeting glycemic, lipid and hypertension management, smoking and other lifestyle factors was shown to reduce the progression and development of cardiac autonomic neuropathy among patients with type 2 diabetes [15]

AM: Interesting

10.1038/s41598-021-01750-0 13 Perez-TilveD.Gonzlez-MatasL.AulingerB

This expansion is fueled by a growing healthcare sector, a large target patient population, and significant unmet clinical needs for diabetes and obesity treatments
Dai Y, Dai D, Wang X, Ding Z, Li C, Mehta JL
